Table 1 Clinical data of the study population
Variables | All population(n = 81) | PaAF (n = 36) | PeAF (n = 45) | P-value |
|---|---|---|---|---|
Age (years) | 61.8 ± 8.8 | 63.2 ± 8.8 | 60.7 ± 8.8 | 0.198 |
Male (n, %) | 57 (70.4) | 26 (72.2) | 31 (68.9) | 0.744 |
BMI (kg/m²) | 25.6 ± 3.0 | 25.5 ± 3.1 | 25.7 ± 3.0 | 0.722 |
Hypertension (n,%) | 30 (37.0) | 12 (33.3) | 18 (40.0) | 0.537 |
Diabetes (n,%) | 11 (13.6) | 5 (13.9) | 6 (13.3) | 1.000 |
CAD (n,%) | 27 (33.3) | 13 (36.1) | 14 (31.1) | 0.635 |
Past Stroke (n,%) | 16 (19.8) | 5 (13.9) | 11 (24.4) | 0.236 |
CHF (n,%) | 11 (13.6) | 6 (16.7) | 5 (11.1) | 0.690 |
Smokers (n,%) | 24 (29.6) | 13 (36.1) | 11 (24.4) | 0.253 |
CHA2DS2-VAScscores | 2.1 ± 1.6 | 2.1 ± 1.6 | 2.2 ± 1.6 | 0.730 |